US Stock MarketDetailed Quotes

ACRV Acrivon Therapeutics

Watchlist

9.400
-0.060-0.63%

Trading Aug 27 09:48 ET

291.14MMarket Cap-3455P/E (TTM)

Acrivon Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

Assets

Current assets

Cash, cash equivalents and short term investments

19.60%180.54M

-8.52%109.98M

-0.23%127.46M

84.96%142.09M

80.01%150.95M

--120.21M

28.26%127.75M

--76.82M

-Cash and cash equivalents

20.83%46.01M

-10.48%24.61M

22.01%36.02M

-6.92%29.86M

-54.60%38.07M

--27.49M

-70.36%29.52M

--32.08M

-Short-term investments

19.18%134.53M

-7.93%85.37M

-6.91%91.44M

150.83%112.23M

--112.88M

--92.72M

--98.23M

--44.74M

Other current assets

-21.78%1.82M

-42.20%2.17M

-48.57%2.23M

29.91%2.4M

-29.48%2.33M

--3.75M

439.63%4.34M

--1.85M

Total current assets

18.97%182.36M

-9.54%112.14M

-1.82%129.69M

83.66%144.49M

75.86%153.28M

--123.96M

31.56%132.1M

--78.67M

Non current assets

Net PPE

17.05%7.44M

15.86%7.61M

15.24%7.91M

-12.94%6.19M

-11.95%6.36M

--6.57M

18.49%6.86M

--7.11M

-Gross PPE

25.85%8.85M

23.57%8.79M

21.72%8.86M

-5.51%7M

-4.97%7.03M

--7.12M

24.54%7.28M

--7.4M

-Accumulated depreciation

-108.90%-1.41M

-116.51%-1.18M

-127.62%-956K

-173.56%-807K

-276.54%-674K

---545K

-650.00%-420K

---295K

Investments and advances

--39.9M

----

--0

--39.28M

--41.88M

----

Non current deferred assets

--468K

--348K

--251K

----

--0

--1.54M

Other non current assets

3.19%421K

7.47%417K

6.70%414K

5.93%411K

5.15%408K

--388K

0.00%388K

--388K

Total non current assets

612.68%48.23M

-81.88%8.38M

-82.55%8.57M

-27.00%6.6M

-13.62%6.77M

--46.23M

695.13%49.13M

--9.04M

Total assets

44.07%230.59M

-29.19%120.52M

-23.71%138.27M

72.26%151.09M

68.48%160.05M

--170.2M

70.03%181.23M

--87.71M

Liabilities

Current liabilities

Payables

-0.47%1.26M

49.64%2.06M

458.41%5.05M

-23.89%1.5M

-33.39%1.27M

--1.37M

-6.22%904K

--1.98M

-accounts payable

-0.47%1.26M

49.64%2.06M

458.41%5.05M

-23.89%1.5M

-33.39%1.27M

--1.37M

-6.22%904K

--1.98M

Current accrued expenses

107.77%6.1M

91.47%4.13M

63.25%3.52M

67.24%4.01M

204.78%2.94M

--2.16M

289.69%2.16M

--2.4M

Current debt and capital lease obligation

29.88%978K

27.57%944K

20.80%877K

8.23%776K

6.66%753K

--740K

9.34%726K

--717K

-Current capital lease obligation

29.88%978K

27.57%944K

20.80%877K

8.23%776K

6.66%753K

--740K

9.34%726K

--717K

Current deferred liabilities

----

--0

4.55%69K

--0

Current liabilities

60.81%11.28M

59.12%9.04M

104.16%13.3M

45.50%9.3M

57.61%7.02M

--5.68M

123.61%6.52M

--6.39M

Non current liabilities

Long term debt and capital lease obligation

-15.72%3.24M

-13.47%3.5M

-11.05%3.77M

-17.56%3.64M

-16.38%3.85M

--4.05M

-14.69%4.24M

--4.42M

-Long term capital lease obligation

-15.72%3.24M

-13.47%3.5M

-11.05%3.77M

-17.56%3.64M

-16.38%3.85M

--4.05M

-14.69%4.24M

--4.42M

Preferred securities outside stock equity

----

--122.52M

Total non current liabilities

-15.72%3.24M

-13.47%3.5M

-11.05%3.77M

-97.13%3.64M

-96.97%3.85M

--4.05M

-96.68%4.24M

--126.94M

Total liabilities

33.70%14.53M

28.93%12.54M

58.78%17.07M

-90.29%12.94M

-91.74%10.87M

--9.73M

-91.76%10.75M

--133.33M

Shareholders'equity

Share capital

40.91%31K

4.55%23K

1,000.00%22K

--22K

1,000.00%22K

--2K

-common stock

40.91%31K

4.55%23K

1,000.00%22K

--22K

1,000.00%22K

--2K

-Preferred stock

--0

----

Retained earnings

-83.43%-151.7M

-93.21%-132.91M

-107.77%-116.42M

-106.29%-97.17M

-118.18%-82.7M

---68.79M

-125.34%-56.03M

---47.1M

Paid-in capital

58.31%367.75M

5.11%240.93M

4.90%237.68M

14,461.00%235.6M

17,404.97%232.29M

--229.23M

21,397.15%226.58M

--1.62M

Gains losses not affecting retained earnings

95.55%-19K

-877.78%-70K

12.63%-83K

-127.07%-302K

---427K

--9K

---95K

---133K

Total stockholders'equity

44.83%216.06M

-32.71%107.98M

-28.91%121.2M

402.85%138.15M

507.87%149.18M

--160.47M

816.01%170.48M

---45.62M

Total equity

44.83%216.06M

-32.71%107.98M

-28.91%121.2M

402.85%138.15M

507.87%149.18M

--160.47M

816.01%170.48M

---45.62M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022
Assets
Current assets
Cash, cash equivalents and short term investments	19.60%180.54M	-8.52%109.98M	-0.23%127.46M	-0.23%127.46M	84.96%142.09M	80.01%150.95M	--120.21M	28.26%127.75M	28.26%127.75M	--76.82M
-Cash and cash equivalents	20.83%46.01M	-10.48%24.61M	22.01%36.02M	22.01%36.02M	-6.92%29.86M	-54.60%38.07M	--27.49M	-70.36%29.52M	-70.36%29.52M	--32.08M
-Short-term investments	19.18%134.53M	-7.93%85.37M	-6.91%91.44M	-6.91%91.44M	150.83%112.23M	--112.88M	--92.72M	--98.23M	--98.23M	--44.74M
Other current assets	-21.78%1.82M	-42.20%2.17M	-48.57%2.23M	-48.57%2.23M	29.91%2.4M	-29.48%2.33M	--3.75M	439.63%4.34M	439.63%4.34M	--1.85M
Total current assets	18.97%182.36M	-9.54%112.14M	-1.82%129.69M	-1.82%129.69M	83.66%144.49M	75.86%153.28M	--123.96M	31.56%132.1M	31.56%132.1M	--78.67M
Non current assets
Net PPE	17.05%7.44M	15.86%7.61M	15.24%7.91M	15.24%7.91M	-12.94%6.19M	-11.95%6.36M	--6.57M	18.49%6.86M	18.49%6.86M	--7.11M
-Gross PPE	25.85%8.85M	23.57%8.79M	21.72%8.86M	21.72%8.86M	-5.51%7M	-4.97%7.03M	--7.12M	24.54%7.28M	24.54%7.28M	--7.4M
-Accumulated depreciation	-108.90%-1.41M	-116.51%-1.18M	-127.62%-956K	-127.62%-956K	-173.56%-807K	-276.54%-674K	---545K	-650.00%-420K	-650.00%-420K	---295K
Investments and advances	--39.9M	----	--0	--0	--0	--0	--39.28M	--41.88M	--41.88M	----
Non current deferred assets	--468K	--348K	--251K	--251K	----	----	----	--0	--0	--1.54M
Other non current assets	3.19%421K	7.47%417K	6.70%414K	6.70%414K	5.93%411K	5.15%408K	--388K	0.00%388K	0.00%388K	--388K
Total non current assets	612.68%48.23M	-81.88%8.38M	-82.55%8.57M	-82.55%8.57M	-27.00%6.6M	-13.62%6.77M	--46.23M	695.13%49.13M	695.13%49.13M	--9.04M
Total assets	44.07%230.59M	-29.19%120.52M	-23.71%138.27M	-23.71%138.27M	72.26%151.09M	68.48%160.05M	--170.2M	70.03%181.23M	70.03%181.23M	--87.71M
Liabilities
Current liabilities
Payables	-0.47%1.26M	49.64%2.06M	458.41%5.05M	458.41%5.05M	-23.89%1.5M	-33.39%1.27M	--1.37M	-6.22%904K	-6.22%904K	--1.98M
-accounts payable	-0.47%1.26M	49.64%2.06M	458.41%5.05M	458.41%5.05M	-23.89%1.5M	-33.39%1.27M	--1.37M	-6.22%904K	-6.22%904K	--1.98M
Current accrued expenses	107.77%6.1M	91.47%4.13M	63.25%3.52M	63.25%3.52M	67.24%4.01M	204.78%2.94M	--2.16M	289.69%2.16M	289.69%2.16M	--2.4M
Current debt and capital lease obligation	29.88%978K	27.57%944K	20.80%877K	20.80%877K	8.23%776K	6.66%753K	--740K	9.34%726K	9.34%726K	--717K
-Current capital lease obligation	29.88%978K	27.57%944K	20.80%877K	20.80%877K	8.23%776K	6.66%753K	--740K	9.34%726K	9.34%726K	--717K
Current deferred liabilities	----	----	--0	--0	--0	--0	--0	4.55%69K	4.55%69K	--0
Current liabilities	60.81%11.28M	59.12%9.04M	104.16%13.3M	104.16%13.3M	45.50%9.3M	57.61%7.02M	--5.68M	123.61%6.52M	123.61%6.52M	--6.39M
Non current liabilities
Long term debt and capital lease obligation	-15.72%3.24M	-13.47%3.5M	-11.05%3.77M	-11.05%3.77M	-17.56%3.64M	-16.38%3.85M	--4.05M	-14.69%4.24M	-14.69%4.24M	--4.42M
-Long term capital lease obligation	-15.72%3.24M	-13.47%3.5M	-11.05%3.77M	-11.05%3.77M	-17.56%3.64M	-16.38%3.85M	--4.05M	-14.69%4.24M	-14.69%4.24M	--4.42M
Preferred securities outside stock equity	----	----	----	----	----	----	----	----	----	--122.52M
Total non current liabilities	-15.72%3.24M	-13.47%3.5M	-11.05%3.77M	-11.05%3.77M	-97.13%3.64M	-96.97%3.85M	--4.05M	-96.68%4.24M	-96.68%4.24M	--126.94M
Total liabilities	33.70%14.53M	28.93%12.54M	58.78%17.07M	58.78%17.07M	-90.29%12.94M	-91.74%10.87M	--9.73M	-91.76%10.75M	-91.76%10.75M	--133.33M
Shareholders'equity
Share capital	40.91%31K	4.55%23K	4.55%23K	4.55%23K	1,000.00%22K	1,000.00%22K	--22K	1,000.00%22K	1,000.00%22K	--2K
-common stock	40.91%31K	4.55%23K	4.55%23K	4.55%23K	1,000.00%22K	1,000.00%22K	--22K	1,000.00%22K	1,000.00%22K	--2K
-Preferred stock	--0	--0	--0	--0	--0	--0	--0	--0	--0	----
Retained earnings	-83.43%-151.7M	-93.21%-132.91M	-107.77%-116.42M	-107.77%-116.42M	-106.29%-97.17M	-118.18%-82.7M	---68.79M	-125.34%-56.03M	-125.34%-56.03M	---47.1M
Paid-in capital	58.31%367.75M	5.11%240.93M	4.90%237.68M	4.90%237.68M	14,461.00%235.6M	17,404.97%232.29M	--229.23M	21,397.15%226.58M	21,397.15%226.58M	--1.62M
Gains losses not affecting retained earnings	95.55%-19K	-877.78%-70K	12.63%-83K	12.63%-83K	-127.07%-302K	---427K	--9K	---95K	---95K	---133K
Total stockholders'equity	44.83%216.06M	-32.71%107.98M	-28.91%121.2M	-28.91%121.2M	402.85%138.15M	507.87%149.18M	--160.47M	816.01%170.48M	816.01%170.48M	---45.62M
Total equity	44.83%216.06M	-32.71%107.98M	-28.91%121.2M	-28.91%121.2M	402.85%138.15M	507.87%149.18M	--160.47M	816.01%170.48M	816.01%170.48M	---45.62M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall